Icade SA
PAR:ICAD
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Icade SA
PAR:ICAD
|
FR |
|
S
|
Suruga Bank Ltd
XMUN:URU
|
JP |
|
A
|
Alexander & Baldwin Inc (Hawaii)
F:ABU
|
US |
|
B
|
Bombardier Inc
XETRA:BBDB
|
CA |
|
Thermo Fisher Scientific Inc
NYSE:TMO
|
US |
|
Abeona Therapeutics Inc
NASDAQ:ABEO
|
US |
|
Lindblad Expeditions Holdings Inc
NASDAQ:LIND
|
US |
|
Bank of China Ltd
HKEX:3988
|
CN |
Wall St Price Targets
ICAD Price Targets Summary
Icade SA
According to Wall Street analysts, the average 1-year price target for
ICAD is 20.87 EUR with a low forecast of 17.17 EUR and a high forecast of 26.25 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is ICAD's stock price target?
Price Target
20.87
EUR
According to Wall Street analysts, the average 1-year price target for
ICAD is 20.87 EUR with a low forecast of 17.17 EUR and a high forecast of 26.25 EUR.
What is the Revenue forecast for Icade SA?
Projected CAGR
-39%
Over the last 14 years, the compound annual growth rate for Revenue has been 0%. The projected CAGR for the next 3 years is -39%.
What is the Operating Income forecast for Icade SA?
Projected CAGR
4%
Over the last 14 years, the compound annual growth rate for Operating Income has been 2%. The projected CAGR for the next 3 years is 4%.